Platelet Rich Plasma Eye Drops for Treatment of Ocular Surface Disease

Summary

The purpose of this study is to evaluate prospectively the efficacy of topical administration of autologous platelet rich plasma as monotherapy for the treatment of symptoms and clinical signs in cases affected by moderate to severe forms of ocular surface disease

Timeline

Start

2021-01

Primary completion

2022-01

Completion

2023-01

Drugs

Indications